|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01873 VIVA BIOTECH
Nominal 
0.930 -0.040 (-4.124%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 115,500 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,350,917 | -10.041% | 1,501,711 | 1,269,870 | 520,290 | 106,348 |
| Land & other Lease Assets | 303,614 | -30.311% | 435,669 | 454,031 | 216,720 | 50,638 |
| Intangible Assets | 2,577,088 | -2.104% | 2,632,480 | 2,687,863 | 2,317,185 | 0 |
| Interests in Asso. & JCEs | 42,403 | -- | 0 | 0 | 0 | 4,228 |
| Other Non-current Assets | 1,029,472 | -27.101% | 1,412,188 | 1,649,209 | 1,748,341 | 643,145 |
| 5,418,994 | -9.412% | 5,982,048 | 6,060,973 | 4,802,536 | 804,359 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 259,707 | -20.343% | 326,031 | 231,721 | 164,745 | 8,530 | |
| Trade Receivables | 407,405 | -8.647% | 445,969 | 429,703 | 320,510 | 57,505 | |
| Cash & Bank Balances | 1,036,322 | 52.722% | 678,569 | 800,947 | 2,308,452 | 904,091 | |
| Other Current Assets | 327,484 | -32.925% | 488,238 | 521,414 | 557,837 | 124,300 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 2,030,918 | 4.751% | 1,938,807 | 1,983,785 | 3,351,544 | 1,094,426 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 245,756 | -24.645% | 326,130 | 281,053 | 295,704 | 7,552 | ||
| S-T Debt & Leases | 952,441 | -50.295% | 1,916,180 | 238,744 | 166,965 | 24,983 | ||
| Other Current Liabilities | 335,981 | -21.910% | 430,247 | 406,806 | 273,003 | 40,428 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 1,534,178 | -42.595% | 2,672,557 | 926,603 | 735,672 | 72,963 | |||
| Net Current Assets | 496,740 | -- | (733,750) | 1,057,182 | 2,615,872 | 1,021,463 | ||
| Total Assets Less Current Liabilities | 5,915,734 | 12.717% | 5,248,298 | 7,118,155 | 7,418,408 | 1,825,822 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 950,776 | 4.854% | 906,760 | 2,415,953 | 2,802,546 | 24,424 | |||
| Other Non-current Liabilities | 1,277,046 | 73.318% | 736,824 | 788,846 | 859,031 | 24,004 | |||
| 2,227,822 | 35.547% | 1,643,584 | 3,204,799 | 3,661,577 | 48,428 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 367 | 12.577% | 326 | 326 | 323 | 261 | ||||
| Reserves | 3,687,545 | 16.027% | 3,178,190 | 3,444,299 | 3,287,777 | 1,777,133 | ||||
| Others | 0 | -- | 426,198 | 468,731 | 468,731 | 0 | ||||
| Shareholders' Funds | 3,687,912 | 2.308% | 3,604,714 | 3,913,356 | 3,756,831 | 1,777,394 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 3,687,912 | 2.308% | 3,604,714 | 3,913,356 | 3,756,831 | 1,777,394 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 166,333 | -49.092% | 326,732 | 491,174 | 267,416 | 355,003 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 116,808,000 |
| %Change | 11430.898% |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 1.753 |